213 related articles for article (PubMed ID: 29121154)
21. Serum levels of interleukin-8 as a marker of disease activity in patients with chronic sarcoidosis.
Yokoyama T; Kanda T; Kobayashi I; Suzuki T
J Med; 1995; 26(5-6):209-19. PubMed ID: 8721898
[TBL] [Abstract][Full Text] [Related]
22. [Secreted interleukin-2 receptor as a parameter of the activity of sarcoidosis].
Strausz J; Müller-Quernheim J; Ferlinz R
Dtsch Med Wochenschr; 1989 May; 114(19):744-9. PubMed ID: 2540943
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-converting enzyme in uveitis and sarcoidosis.
Rømer FK; Schmidt P; Geday H
Acta Ophthalmol (Copenh); 1980 Apr; 58(2):243-9. PubMed ID: 6249067
[TBL] [Abstract][Full Text] [Related]
24. Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.
Kraaijvanger R; Janssen Bonás M; Vorselaars ADM; Veltkamp M
Front Immunol; 2020; 11():1443. PubMed ID: 32760396
[TBL] [Abstract][Full Text] [Related]
25. Assessment of activity in Sarcoidosis. Sensitivity and specificity of 67Gallium scintigraphy, serum ACE levels, chest roentgenography, and blood lymphocyte subpopulations.
Klech H; Kohn H; Kummer F; Mostbeck A
Chest; 1982 Dec; 82(6):732-8. PubMed ID: 6291864
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
[TBL] [Abstract][Full Text] [Related]
27. SACE and IL-2R as serum biomarkers for evaluation of multi-organ involvement and prognosis of sarcoidosis.
Zhou Y; Chen X; Zhao M; Lower EE; Baughman RP
Respir Res; 2023 Sep; 24(1):219. PubMed ID: 37679741
[TBL] [Abstract][Full Text] [Related]
28. Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation.
Young JB; Windsor NT; Smart FW; Kleiman NS; Weilbaecher DG; Noon GP; Nelson DL; Lawrence EC
Transplantation; 1991 Mar; 51(3):636-41. PubMed ID: 2006520
[TBL] [Abstract][Full Text] [Related]
29. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy.
Simsek H; Kadayifci A
J Int Med Res; 1996; 24(3):239-45. PubMed ID: 8725984
[TBL] [Abstract][Full Text] [Related]
30. Soluble interleukin-2 receptors in retinal vasculitis.
Murray PI; Young DW
Curr Eye Res; 1992; 11 Suppl():193-5. PubMed ID: 1424745
[TBL] [Abstract][Full Text] [Related]
31. Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma.
Lai KN; Ho S; Leung JC; Tsao SY
Cancer; 1991 Apr; 67(8):2180-5. PubMed ID: 1848475
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme activity in human aqueous humor.
Weinreb RN; Sandman R; Ryder MI; Friberg TR
Arch Ophthalmol; 1985 Jan; 103(1):34-6. PubMed ID: 2983647
[TBL] [Abstract][Full Text] [Related]
33. Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function.
Lieberman J; Schleissner LA; Nosal A; Sastre A; Mishkin FS
Chest; 1983 Nov; 84(5):522-8. PubMed ID: 6313303
[TBL] [Abstract][Full Text] [Related]
34. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
35. Soluble interleukin-2 receptor in patients with glomerular diseases.
Chen HS; Wu MS; Yen TS; Chen WY
Postgrad Med J; 1995 Oct; 71(840):617-22. PubMed ID: 8545291
[TBL] [Abstract][Full Text] [Related]
36. Serum interleukin 2-receptor levels in uveitis.
Arocker-Mettinger E; Asenbauer T; Ulbrich S; Grabner G
Curr Eye Res; 1990; 9 Suppl():25-9. PubMed ID: 2384010
[TBL] [Abstract][Full Text] [Related]
37. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of soluble interleukin-2 receptor. A marker of disease activity in localized scleroderma.
Uziel Y; Krafchik BR; Feldman B; Silverman ED; Rubin LA; Laxer RM
Arthritis Rheum; 1994 Jun; 37(6):898-901. PubMed ID: 8003062
[TBL] [Abstract][Full Text] [Related]
39. Limited gallium scans and angiotensin converting enzyme in granulomatous uveitis.
Weinreb RN; Barth R; Kimura SJ
Ophthalmology; 1980 Mar; 87(3):202-9. PubMed ID: 6252528
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin converting enzyme. III. Changes in serum level as an indicator of disease activity in untreated sarcoidosis.
Selroos O; Grönhagen-Riska C
Scand J Respir Dis; 1979 Dec; 60(6):328-36. PubMed ID: 231819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
